top of page
Candice and Colin.png
Beauty Awards 2024.jpg
PNCA24 winner footers black.png
Medicine

SWITCH UP TO SELF-CARE:
SELF-CARE DAY 2023

AI INFLUENCER TACKLES TIKTOK HEALTH TREND

Copy of The pill and acne (YouTube) (490 × 510px).png
the-pill-1477278.jpg

CONTRACEPTION IN PHARMACY. 
WHY WAIT?

MAY 2023

MHRA DECISION ON AQUIETTE RECLASSIFICATION

MAY 2023

aquiette-generic-1340x548.jpg
Pharmacist Assisting Customer

WORLD PHARMACISTS DAY 2022:
PHARMACY IN ACTION FOR A HEALTHIER WORLD

MAXWELLIA CEO, ANNA MAXWELL HAS BEEN APPOINTED A FELLOW OF THE ROYAL PHARMACEUTICAL SOCIETY

FN8C75031.jpg
28.png

FORMER PHARMACY SUPERINTENDENT JANICE PERKINS RESPONDS TO AQUIETTE   PUBLIC CONSULTATION

®

PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S SECOND WOMEN’S HEALTH PRODUCT

Aquiette-PC-MHRA-video-overlay.png
aquiette-generic-1600x960.jpg

DR JULIAN SPINKS RESPONDS TO AQUIETTE   PUBLIC CONSULTATION – FOR HEALTH CARE PROFESSIONALS

®

IAN ADAMSON JOINS MAXWELLIA AS STRATEGIC ADVISOR

Ian_Adamson.jpeg
Lovima TV commercial still

MAXWELLIA UNVEILS BOLD £3M 360° SUPPORT CAMPAIGN TO DRIVE AWARENESS OF ITS CONTRACEPTIVE PILL LOVIMA  

®

CHANNEL 4 VENTURES INVESTS IN MAXWELLIA – THE LEADING MEDICINES SWITCH COMPANY

Channel 4 Ventures
UKSPA Breakthrough Issue 13 Maxwellia

GAME CHANGER

Anna Maxwell, the founder and CEO of Maxwellia, tells Breakthrough how her pioneering business will widen access to medicine.

PUSHING THE ON SWITCH

New brands , new pharmacy categories. Next... watch this space.

Anna Maxwell on the front cover of P3Pharmacy magazine August 2021
lovima-packshot-1600x960.jpg

WOMEN CAN BUY MAXWELLIA’S LOVIMA® CONTRACEPTIVE PILL FROM PHARMACIES WITHOUT A PRESCRIPTION FOR FIRST TIME IN UK HISTORY

Wider availability of desogestrel welcomed by UK’s leading women’s health organisations

MAXWELLIA MAKES ‘MOST EXCITING COMPANIES’ LIST IN NORTH WEST BUSINESS INSIDER MAGAZINE

Insider Most Exciting Companies NW
Pharmacist consulting with customer

POWERING UP PHARMACIES

How the High Street hubs can help futureproof the NHS

maxwellia-moon-1600x960.jpg

MAXWELLIA SECURES £500K BRITISH GOVERNMENT BACKED FUTURE FUND INVESTMENT

PRAETURA LEADS SELF CARE FIRM INVESTMENT ROUND

210426-pill-at-the-till.jpg

PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S FIRST WOMEN’S HEALTH PRODUCT

OUR CEO TALKS TO HBW INDUSTRY INSIGHT ABOUT MAXWELLIA’S TRANSITION INTO A CONSUMER HEALTHCARE COMPANY

Anna Maxwell
Anna Maxwell

BIOCITY FEATURE MAXWELLIA CEO ON IWD 2021 CHALLENGING ACCESS TO CONTRACEPTION

SPEARHEADING SHIFT TO SELF CARE WITH THREE PHARMACY PRODUCTS IN LAUNCH PIPELINE

Pharmacists at heart of nation's public health

Maxwellia team at Alderley Park
BioBeat BioBusiness 2019

 TOP MOVER AND SHAKER IN BIOBUSINESS 2019 

Our CEO and founder, Anna Maxwell has been listed in the top 50 movers and shakers of 2019 by BioBusiness 

BIOCITY INVESTS IN MAXWELLIA

Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia

Maxwellia and BioCity
Anna Maxwell, CEO of Maxwellia

POM TO P SWITCHES: WHAT MADE MALOFF PROTECT AND ELLAONE A SUCCESS?

C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of Maxwellia, about what makes a successful POM to P change

The Global Goals for Sustainable Development

THE POWER OF ALIGNING YOUR BUSINESS TO A GLOBAL GOAL 

Maxwellia is mentioned in Forbes for aligning to Global Goal 3 Good Health 

MAXWELLIA EXPANDS TEAM OF SWITCH EXPERTS AS IT BUILDS THE PRODUCT PIPELINE

Appointments will expedite conversion of prescription medicines to over the counter

Dr Emma Quaranta and Alexandra Trehane
Anna Maxwell, Maxwellia and John Smith, PAGB

UK IS FERTILE GROUND FOR SWITCHING 

With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescription-to-OTC reclassification. 

MAXWELLIA ANNOUNCES FUNDING TO ACCELERATE ITS MISSION FOR SELF CARE

Investment will expedite conversion of prescription medicines to over the counter

Maxwellia and Catapult Ventures
bottom of page